Harriet M. Kluger, Alain Patrick Algazi, Rama Balaraman, Elizabeth Iannotti Buchbinder, Wanxing Chai-Ho, Monica F. Chen, Gregory A. Daniels, Tarik Hadid, Leonel Fernando Hernandez-Aya, Ivana Djuretic, Janice M. Mehnert, Daniel Morgensztern, Daniel Olson, Andrew Stewart Poklepovic, Adam Rock, David R. Spigel, Mario Sznol, Sarah A. Weiss, Essie Liu, Jeffrey Ward. "Phase 1A/B study of AB248, a CD8+ selective IL-2 mutein fusion protein, alone or in combination with pembrolizumab, in patients with advanced solid tumor malignancies.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.2616